Carrie E. Carlander McQueen
Director/Board Member at Forest Home Foundation
Profile
Ms. Carrie E.
McQueen is Chief Financial & Accounting Officer at Social Reality, Inc. She is on the Board of Directors at Forest Home Foundation.
Ms. McQueen was previously employed as Chief Financial Officer & Treasurer by LifeVantage Corp.
and Chief Financial Officer & Treasurer by Adventrx Pharmaceuticals, Inc.
She received her undergraduate degree from the University of California San Diego and an MBA from San Diego State University.
Carrie E. Carlander McQueen active positions
| Companies | Position | Start |
|---|---|---|
| Forest Home Foundation | Director/Board Member | - |
Former positions of Carrie E. Carlander McQueen
| Companies | Position | End |
|---|---|---|
| LIFEVANTAGE CORPORATION | Director of Finance/CFO | 2012-07-31 |
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Director of Finance/CFO | 2006-09-04 |
| SRAX, INC. | Director of Finance/CFO | 2016-04-12 |
Training of Carrie E. Carlander McQueen
| San Diego State University | Masters Business Admin |
| University of California San Diego | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| LIFEVANTAGE CORPORATION | Health Technology |
| SRAX, INC. | Technology Services |
| Private companies | 2 |
|---|---|
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Health Technology |
| Forest Home Foundation |
- Stock Market
- Insiders
- Carrie E. Carlander McQueen
